Missed Periods: Drugs That Cause or Treat It, and What Your Cycle Is Telling You

Why Your Period Stopped: The Short Answer

Your menstrual cycle is a finely tuned hormonal conversation between your brain, your ovaries, and your uterus. When any part of that conversation breaks down, your period can disappear. The medical term is secondary amenorrhea: no menstrual bleeding for three or more consecutive months in a woman who has previously had periods. Primary amenorrhea, by contrast, is when periods never start by age 15.

Before anything else: rule out pregnancy. A urine pregnancy test is the first step in any workup for a missed period, regardless of your contraceptive use or sexual history.

How the Menstrual Cycle Works (and Where Drugs Interfere)

The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. Those pulses tell the pituitary to release FSH and LH. FSH grows a follicle; LH triggers ovulation. The corpus luteum left behind makes progesterone. If no pregnancy occurs, progesterone drops and you bleed.

Drugs can disrupt this axis at multiple points. Some suppress GnRH pulses directly. Others raise prolactin, which inhibits GnRH. Some thin the uterine lining so there is nothing to shed. Understanding where the interruption happens tells your clinician which treatment will work.

Life Stage Matters

• Reproductive years (roughly ages 15-45): Pregnancy, contraception, PCOS, and stress are the most common culprits.
• Perimenopause (typically ages 45-55): Cycles become irregular or absent as ovarian reserve declines. Missing a period here may mean perimenopause, not a problem, though pregnancy remains possible until 12 consecutive months of no periods confirm menopause.
• Post-menopause: Any bleeding at all warrants evaluation; absence of periods is expected and normal.
• Postpartum and lactation: Lactational amenorrhea is physiologic. Breastfeeding suppresses GnRH pulses through elevated prolactin, often preventing periods for months.

Drugs That Commonly Cause Missed Periods

Several medication classes reliably disrupt the hypothalamic-pituitary-ovarian (HPO) axis. Your prescribing clinician may not have warned you. Here is what the evidence shows.

Hormonal Contraceptives

This is the most common drug-related reason for missed periods in women of reproductive age.

Combined oral contraceptives (COCs): COCs suppress ovulation by delivering steady estrogen and progestin. The "period" you get on a traditional pack is a withdrawal bleed, not a true menstrual period. Some women on continuous cycling regimens (skipping the placebo week) have no bleeding at all, which is intentional and considered safe.

Progestin-only methods: The hormonal IUD (levonorgestrel-releasing, e.g., Mirena, Liletta) thins the endometrial lining so significantly that up to 50% of users report no periods after 12 months of use. The contraceptive implant (etonogestrel, Nexplanon) causes amenorrhea in approximately 22% of users. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) causes amenorrhea in roughly 50% of users by 12 months and up to 80% by 24 months.

Post-pill amenorrhea: After stopping COCs, most women resume ovulation within 1-3 months. Persistent amenorrhea beyond 3 months after stopping is not caused by the pill itself but uncovers an underlying issue, often PCOS or hypothalamic dysfunction, that the pill was masking.

Antipsychotics and Mood-Stabilizing Drugs

Antipsychotic medications are among the most pharmacologically potent causes of amenorrhea in women of reproductive age.

How it happens: Dopamine normally inhibits prolactin secretion from the pituitary. Dopamine-blocking antipsychotics (D2 antagonists) remove that brake, causing prolactin to rise. High prolactin suppresses GnRH pulses. The result: no ovulation, no period.

The highest-risk agents include haloperidol, risperidone, and paliperidone, which produce the largest prolactin elevations. Aripiprazole, a partial dopamine agonist, raises prolactin minimally and is sometimes substituted when menstrual disruption is a concern.

Lithium and valproate can also disrupt cycles, potentially through thyroid or direct ovarian effects. Valproate specifically is associated with PCOS-like hormonal patterns, including elevated androgens and irregular periods, particularly in women with epilepsy.

Chemotherapy and Endocrine Therapies

Cytotoxic chemotherapy can damage the ovarian follicle pool directly, causing temporary or permanent amenorrhea depending on the agent, dose, and your age at treatment. Alkylating agents (cyclophosphamide, busulfan) carry the highest risk. Women under 30 have a much better chance of cycle recovery than women over 40.

Tamoxifen (used for ER-positive breast cancer) causes irregular or absent periods in pre-menopausal women. It is not a contraceptive despite stopping periods. Pregnancy must be actively prevented during tamoxifen use (see pregnancy section below).

GnRH agonists such as leuprolide (Lupron) and goserelin (Zoladex) are intentionally used to suppress ovarian function, creating a medically induced, reversible menopause. They are used in endometriosis, fibroids, and breast cancer. Periods return within 3-6 months of stopping in most women.

Antidepressants

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may cause cycle irregularity in some women, likely through modest prolactin elevation. The effect is generally less pronounced than with antipsychotics. Case series and pharmacovigilance data document amenorrhea with fluoxetine, sertraline, and venlafaxine, but well-controlled prospective studies are limited. This is an area where the evidence in women is genuinely thin.

Corticosteroids and Other Hormonal Agents

Long-term systemic corticosteroid use (e.g., prednisone for autoimmune disease) suppresses the HPO axis and can cause amenorrhea, separate from any weight changes. Anabolic steroids and exogenous androgens (including testosterone prescribed off-label) suppress LH and FSH and stop periods, often within weeks of starting.

Opioids deserve specific mention. Chronic opioid use causes opioid-induced hypogonadism in a large proportion of women, with studies suggesting amenorrhea rates of 40-80% in women on long-term opioid therapy for pain. This is underrecognized in clinical practice.

Non-Drug Medical Causes You Should Know About

Drugs are one piece of the puzzle. Your clinician will also consider these conditions, several of which are female-specific.

PCOS

Polycystic ovary syndrome affects 8-13% of women of reproductive age worldwide and is the most common endocrine disorder in this group. Elevated androgens disrupt follicular development and prevent regular ovulation, causing cycles to lengthen, become unpredictable, or stop entirely. Insulin resistance amplifies androgen production. PCOS does not go away at menopause, though the hormonal picture shifts.

Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism alter menstrual patterns. Hypothyroidism tends to cause heavier, more frequent periods in early stages and then amenorrhea if severe. Hyperthyroidism more commonly shortens cycles or causes oligomenorrhea. TSH testing is part of any standard amenorrhea workup.

Hypothalamic Amenorrhea

When calorie intake is too low, body fat drops below a threshold the brain recognizes as safe for reproduction, or psychological stress is extreme, the hypothalamus reduces GnRH pulse frequency. This is called functional hypothalamic amenorrhea (FHA). It is common in athletes, dancers, women with restrictive eating disorders, and anyone under severe chronic stress. The 2017 Endocrine Society guideline on FHA recommends addressing the underlying energy deficit before pharmacologic intervention.

Hyperprolactinemia Not from Drugs

A pituitary adenoma (prolactinoma) secretes prolactin autonomously. Symptoms mirror drug-induced hyperprolactinemia: absent periods, sometimes galactorrhea (nipple discharge). An MRI of the pituitary and a serum prolactin level distinguish drug effect from tumor.

Premature Ovarian Insufficiency

POI (sometimes called premature menopause) is the loss of normal ovarian function before age 40. It affects approximately 1% of women under 40. FSH will be elevated (typically above 25 IU/L on two occasions, 4 weeks apart), and estradiol will be low. POI requires hormone therapy for bone, cardiovascular, and cognitive protection until the natural age of menopause.

Drugs Used to Treat or Restore Missed Periods

Treatment depends completely on the cause. There is no universal "bring back my period" medication.

Progestin Challenge and Cyclic Progesterone

If the uterus and outflow tract are intact and estrogen levels are adequate, a progestin challenge (medroxyprogesterone acetate 10 mg daily for 10 days, or micronized progesterone 200 mg nightly for 12 days) will produce a withdrawal bleed within 2 weeks of stopping. A bleed confirms the endometrium was primed with estrogen and the uterus can respond. No bleed points toward either low estrogen or an anatomical obstruction.

Cyclic progesterone is also used to regulate periods in women with PCOS who are not trying to conceive, protecting the endometrium from unopposed estrogen exposure, which over time raises the risk of endometrial hyperplasia and cancer.

Clomiphene and Letrozole for Ovulation Induction

For women with PCOS or hypothalamic amenorrhea who want to conceive, ovulation induction is the primary treatment.

Letrozole (an aromatase inhibitor, 2.5-7.5 mg on cycle days 3-7) is now the first-line agent per ASRM guidelines for ovulation induction in PCOS, having demonstrated higher live birth rates than clomiphene in the PPCOSS and NEJM 2014 Legro trial (27.5% vs. 19.1% cumulative live birth rate per woman).

Clomiphene citrate (50-150 mg on cycle days 3-7 or 5-9) remains widely used for women who cannot access letrozole. Both are oral agents taken for 5 days early in the cycle.

Cabergoline for Hyperprolactinemia

When elevated prolactin is the cause (whether from a drug or a prolactinoma), cabergoline (a dopamine agonist, typically 0.25-0.5 mg twice weekly) reduces prolactin and restores GnRH pulsatility. Cabergoline is more effective and better tolerated than bromocriptine for prolactinoma. Most women resume periods within 2-3 months.

GnRH Therapy for Hypothalamic Amenorrhea

Pulsatile GnRH administration (via pump) mimics the normal hypothalamic signal and can restore ovulation in women with FHA. It is available in limited centers and primarily used when fertility is the goal. The Endocrine Society guideline notes pulsatile GnRH as effective but logistically complex.

Metformin and Inositol for PCOS

Metformin (500-2000 mg daily) reduces insulin resistance in PCOS and can restore ovulation as a secondary effect. It is not a direct ovulation inducer. A 2012 Cochrane review found metformin improved ovulation rates versus placebo but was inferior to clomiphene for live birth. Myo-inositol (2-4 g daily) has a growing evidence base for improving insulin sensitivity and cycle regularity in PCOS, though large RCT data remain limited.

Hormone Therapy for POI and Perimenopause

Women with POI need estrogen replacement. The standard approach is an estrogen dose equivalent to what healthy premenopausal ovaries produce (e.g., oral estradiol 2 mg daily or a 100 mcg transdermal patch), combined with a progestogen to protect the endometrium, continued until the average age of natural menopause (51-52). ACOG recommends hormone therapy for POI for both symptom management and long-term health protection.

For perimenopausal women with cycle irregularity but intact ovarian function, low-dose combined hormonal contraception can regulate bleeding and manage symptoms while providing contraception (fertility remains possible in perimenopause).

Pregnancy, Lactation, and Contraception: What You Must Know

This section applies to every drug discussed above and every woman who is not yet in confirmed post-menopause.

Rule Out Pregnancy First, Always

A missed period in any woman with a uterus who could theoretically be pregnant requires a urine hCG test before any other investigation or treatment. This includes women using contraception: no method is 100% effective. Administering a progestin challenge, starting metformin, or ordering imaging without ruling out pregnancy first is a clinical error.

Drug-Specific Pregnancy and Lactation Considerations

Hormonal contraceptives: COCs, the patch, and the ring are FDA Pregnancy Category X: contraindicated in pregnancy. They do not cause birth defects if inadvertently taken early in pregnancy, but should be stopped immediately when pregnancy is confirmed. All progestin-only methods are also stopped in pregnancy. Levonorgestrel from a hormonal IUD transfers minimally into breast milk; the American College of Obstetricians and Gynecologists considers hormonal IUDs compatible with breastfeeding.

Tamoxifen: Tamoxifen is teratogenic. ACOG and ASCO guidelines require reliable non-hormonal contraception (copper IUD or barrier methods) throughout treatment and for at least 3 months after stopping. Do not rely on tamoxifen-induced amenorrhea as contraception.

Cabergoline: Available data from over 800 pregnancies do not show elevated fetal risk with cabergoline exposure in early pregnancy. Most clinicians stop cabergoline once pregnancy is confirmed for a microprolactinoma, since the tumor rarely grows significantly during pregnancy. Cabergoline suppresses prolactin and will inhibit lactation if taken postpartum.

Clomiphene: Not for use in pregnancy. Multiple pregnancy (twins) occurs in approximately 5-8% of clomiphene cycles, compared with about 1% in the general population. Clomiphene transfers into breast milk and is not recommended during breastfeeding.

Letrozole: Also not for use in pregnancy. Early concern about teratogenicity has not been confirmed in larger registries, but it remains contraindicated in pregnancy. Women should have a negative pregnancy test before each treatment cycle.

Metformin: FDA Pregnancy Category B. Used by some clinicians through the first trimester in PCOS pregnancies to reduce miscarriage risk, though evidence is mixed. Metformin is present in breast milk at low levels and is generally considered compatible with breastfeeding by most guidelines.

GnRH agonists (leuprolide, goserelin): Contraindicated in pregnancy. Leuprolide is FDA Pregnancy Category X. Women must use non-hormonal contraception if there is any chance of pregnancy before starting these agents.

Valproate: Strongly teratogenic. Associated with neural tube defects, facial abnormalities, and cognitive impairment. Women of reproductive potential on valproate must use highly effective contraception. The FDA Black Box Warning and ACOG both require counseling before prescribing valproate to women who could become pregnant.

Lactational Amenorrhea as Contraception

Full breastfeeding (no supplemental feeds, nursing at least every 4-6 hours, day and night) suppresses ovulation through elevated prolactin in the first 6 months postpartum. The Lactational Amenorrhea Method (LAM) has a failure rate below 2% when all three criteria are met: amenorrhea, full breastfeeding, and less than 6 months postpartum. Once any criterion breaks, additional contraception is needed.

Who This Is Right For (and Not Right For): A Life-Stage Guide

Reproductive Years, Not Trying to Conceive

If you are not trying to get pregnant and your periods have stopped or become irregular, the goal is identifying the cause and protecting your endometrium and bone density. Unopposed estrogen from anovulation (common in PCOS) raises endometrial cancer risk. Extended amenorrhea from low estrogen (hypothalamic amenorrhea, POI) reduces bone density. Either situation warrants medical attention. Cyclic progestogen or a combined hormonal contraceptive addresses both problems if the cause is anovulation.

Trying to Conceive

Absent periods mean absent ovulation in most cases, so the priority is restoring ovulation. Letrozole or clomiphene are first-line for PCOS. Nutritional rehabilitation and stress reduction are first-line for hypothalamic amenorrhea, with ovulation induction added if weight restoration alone does not restore cycles within 6 months. Referral to a reproductive endocrinologist is appropriate after 3-6 months of failed outpatient treatment.

Perimenopause

Skipped periods in your mid-to-late 40s may simply be perimenopause. An FSH above 25 IU/L on cycle days 2-5, or rising over time, alongside symptoms like hot flashes, sleep disruption, or vaginal dryness, supports this. Pregnancy is still possible. Women in perimenopause who do not want to become pregnant need contraception until 12 months of confirmed amenorrhea (confirmed menopause). Low-dose combined hormonal contraception or a progestin-only method works here.

Post-Menopause

No periods is normal and expected. Any uterine bleeding in a post-menopausal woman, even spotting, requires evaluation to rule out endometrial pathology, not reassurance.

When to Seek Care: Specific Timelines

Do not wait indefinitely. Seek care if:

• Your period has been absent for 3 or more months and pregnancy has been ruled out.
• You have missed 3 periods after stopping a hormonal contraceptive.
• You experience galactorrhea (nipple discharge not from breastfeeding) alongside missed periods, which raises suspicion for hyperprolactinemia.
• You have hot flashes, night sweats, and vaginal dryness with missed periods before age 40, which may indicate POI.
• You have significant unintentional weight loss, excessive exercise, or a history of disordered eating alongside missed periods.
• You are on an antipsychotic, opioid, or hormonal cancer therapy and your periods have stopped.

A standard first workup includes: urine pregnancy test, serum prolactin, TSH, FSH, LH, estradiol, and (if PCOS is suspected) total testosterone and DHEA-S. Your clinician may add an AMH level to assess ovarian reserve or a pelvic ultrasound to evaluate ovarian morphology and endometrial thickness.

As WomanRx medical reviewer Elena Vasquez, MD, notes: "The most common mistake I see is women and their clinicians attributing absent periods solely to stress or their contraception, and waiting a year or more before investigating. Three missed periods in a row is a clear signal to check prolactin, TSH, and FSH. Finding hypothyroidism or a small prolactinoma early means simple, effective treatment and no lasting impact on fertility or bone health."